AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in AN2 Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q2 2025
- Shares held
- 8.28M
- −8.24K (−0.1%) vs. Q2 2025
- Total value
- $10.5M
- +$1.73M (+19.7%) vs. Q2 2025
- New holders
- 2
- 7 more added
- Sold out
- 3
- 11 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Almitas Capital LLC | 1,428,323 | $1.81M | 0.42% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,080,070 | $1.37M | 0.00% | +44,123+4.3% | Added |
| Pfizer Inc | 715,295 | $908.4K | 0.21% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 589,216 | $748.3K | 0.67% | +6,446+1.1% | Added |
| Stonepine Capital Management, LLC | 563,913 | $716.2K | 0.58% | +19,419+3.6% | Added |
| Bank of Nova Scotia | 459,194 | $583.2K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 456,463 | $579.7K | 0.04% | −38,933−7.9% | Reduced |
| Bank of Montreal | 422,077 | $536.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 385,597 | $489.7K | 0.00% | −13,257−3.3% | Reduced |
| Bank of America Corp | 385,310 | $489.3K | 0.00% | −201−0.1% | Reduced |
| BlackRock, Inc. | 320,911 | $407.6K | 0.00% | +1,616+0.5% | Added |
| Two Sigma Advisers, LP | 267,900 | $340.2K | 0.00% | −1,700−0.6% | Reduced |
| Geode Capital Management, LLC | 249,351 | $316.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 223,337 | $283.6K | 0.00% | −15,010−6.3% | Reduced |
| Morgan Stanley | 190,770 | $242.3K | 0.00% | +12,527+7.0% | Added |
| State Street Corp | 87,002 | $110.5K | 0.00% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 65,000 | $82.5K | 0.08% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 64,267 | $81.6K | 0.00% | +54,205+538.7% | Added |
| Bridgeway Capital Management, LLC | 59,900 | $76.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 56,694 | $72.0K | 0.00% | −5,306−8.6% | Reduced |
| Northern Trust Corp | 43,196 | $54.9K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 40,000 | $50.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,013 | $29.2K | 0.00% | +10,516+84.1% | Added |
| Private Advisor Group, LLC | 22,500 | $28.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 18,541 | $23.5K | 0.00% | −7,503−28.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 14,281 | $18.1K | 0.00% | −2,834−16.6% | Reduced |
| ACT Advisors, LLC. | 13,199 | $16.8K | 0.01% | +13,199 | New |
| Federated Hermes, Inc. | 11,882 | $15.1K | 0.00% | −355−2.9% | Reduced |
| Qube Research & Technologies Ltd | 10,184 | $12.9K | 0.00% | 00.0% | Unchanged |
| Highline Wealth Partners LLC | 5,000 | $6.35K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,128 | $2.70K | 0.00% | −3,185−59.9% | Reduced |
| Innovative Advisory Group, LLC | 1,170 | $1.49K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,000 | $1.27K | 0.00% | +1,000 | New |
| BNP Paribas Arbitrage, SA | 303 | $385 | 0.00% | −9−2.9% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $384 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 200 | $254 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −45,320−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,678−100.0% | Sold out |